Lightox

LightOx is developing new therapies for mouth cancers, focusing on light-activated cytotoxic therapeutics that target cancerous cells with minimal off-target toxicity

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical development

Model

01Company Overview

LightOx is developing new therapies for mouth cancers, focusing on light-activated cytotoxic therapeutics that target cancerous cells with minimal off-target toxicity.

02Backed By1 investor

PVPXN Ventures→

03Similar Companies